NeuRizer advances Leigh Creek urea project as funding and Indian deal progress

NeuRizer Ltd ( (AU:NRZ) ) just unveiled an announcement.

NeuRizer raised $350,000 through two small private share placements in the March quarter to bolster general working capital, underscoring its reliance on incremental funding as it advances project development. The capital structure moves come as the company works to position itself for future revenue from large-scale fertiliser production rather than current operations.

During the period, NeuRizer progressed Stage 1 of the NeuRizer Urea Project after federal authorities finalised Environmental Impact Statement guidelines, moving the project closer to final approvals and first urea production. Stage 1 remains a declared Major Project in South Australia, reinforcing NeuRizer’s ambitions to become a key domestic and international urea supplier while promising potential economic benefits.

For Stage 2, which is planned to deliver an initial 1 million tonnes of urea annually, NeuRizer continued collaborating with DL E&C to split the EPCC scope into separate engineering/procurement and construction/commissioning contracts, a step that could improve cost control and competitive tendering. The company also narrowed its international ambitions in India to a single counterparty, resulting in a non-binding term sheet and letters of award for a licensing deal and sale of redundant Leigh Creek plant and equipment, signalling early monetisation and technology export opportunities.

More about NeuRizer Ltd

NeuRizer Ltd is an Australian resources and chemicals company focused on developing the NeuRizer Urea Project (NRUP) at Leigh Creek in South Australia. The project targets large-scale domestic and export production of urea fertiliser, aiming to improve supply chain security for Australian farmers and support sustainable agricultural solutions in global markets.

Average Trading Volume: 9,997,589

Technical Sentiment Signal: Sell

Current Market Cap: A$3.36M

Find detailed analytics on NRZ stock on TipRanks’ Stock Analysis page.